|Day Low/High||33.26 / 33.48|
|52 Wk Low/High||17.57 / 47.35|
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Akorn,...
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.
M&A, French election relief and renewed talk of reforms to taxes and trade all helped to push European stocks higher Tuesday
Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Akorn, Inc.
Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.
Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion and the biosimilars unit of German peer Merck KGaA.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADS, AKRX, CSS, DISCA, GPS, LOCO Downgrades: CVTI, NCR Initiations: FLOW Read on to get TheStreet Quant Ratings' detailed report:
OncoMed Pharmaceuticals, Geron and Akorn were among the biotech stock movers in premarket trading on Monday.
Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.
Here are Monday's top research calls, including upgrades for FedEx, Garmin and HP, and a downgrade for GoPro.
Here's a technical look at how to play a number of stocks trending higher with strong volume.
Risk-tolerant investors should consider buying this stock on further dips.
The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 1,867,919 share decrease in total short interest for Akorn Inc , to 10,324,737, a decrease of 15.32% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.